LONDON - Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever after two potential drugs showed survival rate of as much as 90% in a clinical trial in Congo.
They showed"clearly better" results in patients in a trial of four potential treatments being conducted during the world's second largest Ebola outbreak in history, now entering its second year in DRC. Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, told reporters in a telebriefing the results were"very good news" for the fight against Ebola.
In comparison, two-third of the patients who got remdesivir and nearly three-fourth on ZMapp survived. The Congo treatment trial, which began in November last year, is being carried out by an international research group coordinated by the World Health Organization . Jeremy Farrar, director of the Wellcome Trust global health charity, also hailed the success of the trial's findings, saying they would"undoubtedly save lives".
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »